New York, New York (PRWEB) December 09, 2013
Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) involving allegations that the use of Tylenol brand drugs caused plaintiffs to develop liver failure continue to mount in courts around the country, Bernstein Liebhard LLP reports. Most recently, a Tylenol lawsuit was filed on behalf of a California woman who allegedly suffered acute liver failure and massive necrosis consistent with acetaminophen hepatotoxicity due to her use of Extra Strength Tylenol. The case was filed on November 13, 2013, in the U.S. District Court, Eastern District of Pennsylvania, where approximately 100 similar claims alleging liver injuries due to Tylenol have been consolidated in a multidistrict litigation. (Case No. 2:13-cv-06597-LS)
“We have heard from a number of individuals who allegedly suffered liver failure following use of a Tylenol product. Their experiences echo the claims being put forth by this Plaintiff,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Tylenol lawsuit reviews to victims of severe liver damage allegedly associated with the use of Tylenol-brand medications.
According to court documents, the multidistrict litigation for Tylenol lawsuits was established in the Eastern District of Pennsylvania this past April. All of the claims pending in the proceeding similarly allege that over-the-counter acetaminophen containing products sold under the Tylenol brand-name caused liver damage, including liver failure, even when taken as directed. According to an order issued by the Court in October, the selection of individual Tylenol lawsuits as possible candidates for the proceeding’s first bellwether trials will conclude by April 2014. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
The U.S. Food & Drug Administration (FDA) has stated that acetaminophen, the active ingredient in Tylenol products, was the leading cause of acute liver failure in the U.S. between 1998 and 2003. From 1990 to 1998, acetaminophen was blamed to 56,000 emergency room visits, 26,000 hospitalizations, and 458 deaths annually.
This past summer, Bloomberg.com reported that Johnson & Johnson would be adding more prominent, red-lettered warnings to the labels of Tylenol products regarding the potential for sever liver damage. Those warnings first appeared on Extra Strength Tylenol in October, which currently contain 500 milligrams of acetaminophen per pill. The FDA cut the amount of acetaminophen that prescription products could contain to 325 milligrams per pill two years ago, Bloomberg said.*
Tylenol users who experienced hospitalization, liver transplantation or death allegedly due to their use of one of these over-the-counter medications could be entitled to compensation for their injury-related damages. [Find out more about filing a Tylenol lawsuit by visiting Bernstein Liebhard LLP’s website. For a free evaluation of your claim, please call 800-511-5092.
*bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP